Image

Fontan Fitness Trial

Fontan Fitness Trial

Recruiting
10-17 years
All
Phase N/A

Powered by AI

Overview

The goal of this randomized control trial is to learn about physical fitness and exercise habits in children aged 10-17 with the Fontan Circulation through a home-based, digital exercise intervention. The main questions it aims to answer are:

  • Does a home-based, digital intervention increase physical activity (PA) in youth with the FC compared to enhanced usual care?
  • Does a home-based, digital intervention increase physical fitness in youth with the FC compared to enhanced usual care?
  • Do multi-level factors (medical, neurodevelopmental, sociodemographic, neighborhood) impact the effectiveness of the digital intervention?

Researchers will compare participants in the enhanced usual care arm to those in the exercise intervention arm to see if the digital intervention is effective.

All participants will wear a PA tracker for 12 months and complete testing at baseline, 6 months, and 12 months.

In addition, participants in the exercise intervention arm will complete a 6-month exercise intervention with the following components:

  • aerobic exercise
  • resistance exercise
  • engagement strategies

Description

The Fontan Circulation is associated with poor exercise performance and reduced quality of life. Current standard of care encourages physical activity (PA) in this population, but few structured interventions exist. Participants will be randomly assigned to either enhanced usual care (PA tracker and standard encouragement) or an interactive digital intervention that includes personalized aerobic and resistance exercises with behavioral engagement strategies. This study will evaluate a home-based, digital intervention delivered through a mobile health platform to promote PA and improve fitness among youth with FC.

The study will recruit up to 200 participants aged 10-17 years with FC. After initial testing and a two-week run-in period, 120 participants with peak VO2 between 45% and 80% of predicted norms will be randomized. The intervention will last 6 months, followed by a 5.5-month monitoring phase. Outcomes will include changes in PA (measured via accelerometry), peak VO2, muscle strength, body composition, and quality of life.

Eligibility

Inclusion Criteria:

  • Fontan Circulation present
  • Girls ≥11 years of age or menstruating must have negative urine pregnancy test
  • Neurodevelopmental capacity to complete all study procedures
  • Physical capacity to complete all study procedures
  • English speaking with at least one English speaking parent/guardian
  • To enroll in the randomized control trial, percent predicted peak VO2 <80% of age-sex matched normal controls on the baseline exercise stress test (EST)

Exclusion Criteria:

  • Inability to complete an EST at any time (i.e. limited physical or executive function)
  • Uncontrolled lymphatic disorders
  • Exercise induced or uncontrolled arrhythmias
  • Pacemaker or internal cardiac defibrillator (ICD)
  • Peak VO2 <45% age-sex predicted
  • Having had or under consideration for a heart transplant
  • Pregnant or lactating females
  • Parents/guardians or subjects who, in the opinion of the investigator, may be non-compliant with study schedules or procedures

Study details
    Single-ventricle
    Congenital Heart Disease

NCT06918795

Children's Hospital of Philadelphia

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.